Macrophage fusion, giant cell formation, and the foreign body response require matrix metalloproteinase 9

Journal of Leukocyte Biology

Volumn 85, Issue 4, 2009, Pages 617-626

  MacLauchlan, Susan ^a   Skokos, Eleni A ^a   Meznarich, Norman ^b   Zhu, Dana H ^a   Raoof, Sana ^a   Shipley, J Michael ^c   Senior, Robert M ^c   Bornstein, Paul ^b   Kyriakides, Themis R ^a  

^a YALE UNIVERSITY   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Cell fusion; Extracellular matrix; Monocyte macrophages

Indexed keywords

BLOCKING ANTIBODY; CELLULOSE; GELATINASE B; INTERLEUKIN 4; POLYVINYL ALCOHOL;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; CELL FUSION; CELL STRUCTURE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; FOREIGN BODY; GIANT CELL; HISTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; WILD TYPE; ANIMAL; BONE MARROW CELL; CELL CULTURE; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY;

MUS;

ANIMALS; BONE MARROW CELLS; CELL FUSION; CELLS, CULTURED; EXTRACELLULAR MATRIX; FOREIGN BODIES; GIANT CELLS; GIANT CELLS, FOREIGN-BODY; INTERLEUKIN-4; MACROPHAGES; MATRIX METALLOPROTEINASE 9; MICE; MICE, KNOCKOUT;

EID: 65249126721     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1008588     Document Type: Article

References (53)

1. Sapir, A., Avinoam, O., Podbilewicz, B., Chernomordik, L. V. (2008) Viral and developmental cell fusion mechanisms: conservation and divergence. Dev. Cell 14, 11-21.
2. Oren-Suissa, M., Podbilewicz, B. (2007) Cell fusion during development. Trends Cell Biol. 17, 537-546.
3. Chen, E. H., Olson, E. N. (2005) Unveiling the mechanisms of cell- cell fusion. Science 308, 369-373.
4. Vignery, A. (2005) Macrophage fusion: the making of osteoclasts and giant cells. J. Exp. Med. 202, 337-340. (Pubitemid 41126949)
5. Anderson, J. M., Rodriguez, A., Chang, D. T. (2008) Foreign body reaction to biomaterials. Semin Immunol. 20, 86-100.
6. Yagi, M., Miyamoto, T., Sawatani, Y., Iwamoto, K., Hosogane, N., Fujita, N., Morita, K., Ninomiya, K., Suzuki, T., Miyamoto, K., Oike, Y., Takeya, M., Toyama, Y., Suda, T. (2005) DC-STAMP is essential for cell- cell fusion in osteoclasts and foreign body giant cells. J. Exp. Med. 202, 345-351. (Pubitemid 41126951)
7. Jay, S. M., Skokos, E., Laiwalla, F., Krady, M. M., Kyriakides, T. R. (2007) Foreign body giant cell formation is preceded by lamellipodia formation and can be attenuated by inhibition of Rac1 activation. Am. J. Pathol. 171, 632-640. (Pubitemid 47344695)
8. Moreno, J. L., Mikhailenko, I., Tondravi, M. M., Keegan, A. D. (2007) IL-4 promotes the formation of multinucleated giant cells from macrophage precursors by a STAT6-dependent, homotypic mechanism: contribution of E-cadherin. J. Leukoc. Biol. 82, 1542-1553. (Pubitemid 350276966)
9. Helming, L., Tomasello, E., Kyriakides, T. R., Martinez, F. O., Takai, T., Gordon, S., Vivier, E. (2008) Essential role of DAP12 signaling in macrophage programming into a fusion-competent state. Sci. Signal. 1, ra11.
10. Helming, L., Gordon, S. (2007) The molecular basis of macrophage fusion. Immunobiology 212, 785-793.
11. Kyriakides, T. R., Bornstein, P. (2003) Matricellular proteins as modulators of wound healing and the foreign body response. Thromb. Haemost. 90, 986-992.
12. Luttikhuizen, D. T., Harmsen, M. C., Van Luyn, M. J. (2006) Cellular and molecular dynamics in the foreign body reaction. Tissue Eng. 12, 1955-1970. (Pubitemid 44162854)
13. Zhao, Q., Topham, N., Anderson, J. M., Hiltner, A., Lodoen, G., Payet, C. R. (1991) Foreign-body giant cells and polyurethane biostability: in vivo correlation of cell-adhesion and surface cracking. J. Biomed. Mater. Res. 25, 177-183.
14. Ratner, B. D. (2002) Reducing capsular thickness and enhancing angiogenesis around implant drug release systems. J. Control. Release 78, 211-218.
15. Helming, L., Gordon, S. (2007) Macrophage fusion induced by IL-4 alternative activation is a multistage process involving multiple target molecules. Eur. J. Immunol. 37, 33-42. (Pubitemid 46128784)
16. Kyriakides, T. R., Foster, M. J., Keeney, G. E., Tsai, A., Giachelli, C. M., Clark-Lewis, I., Rollins, B. J., Bornstein, P. (2004) The CC chemokine ligand, CCL2/MCP1, participates in macrophage fusion and foreign body giant cell formation. Am. J. Pathol. 165, 2157-2166. (Pubitemid 39578392)
17. Keselowsky, B. G., Bridges, A. W., Burns, K. L., Tate, C. C., Babensee, J. E., LaPlaca, M. C., Garcia, A. J. (2007) Role of plasma fibronectin in the foreign body response to biomaterials. Biomaterials 28, 3626-3631.
18. Kyriakides, T. R., Leach, K. J., Hoffman, A. S., Ratner, B. D., Bornstein, P. (1999) Mice that lack the angiogenesis inhibitor, thrombospondin 2, mount an altered foreign body reaction characterized by increased vascularity. Proc. Natl. Acad. Sci. USA 96, 4449-4454.
19. Kyriakides, T. R., Zhu, Y. H., Yang, Z., Huynh, G., Bornstein, P. (2001) Altered extracellular matrix remodeling and angiogenesis in sponge granulomas of thrombospondin 2-null mice. Am. J. Pathol. 159, 1255-1262. (Pubitemid 32947955)
20. Yang, Z., Kyriakides, T. R., Bornstein, P. (2000) Matricellular proteins as modulators of cell-matrix interactions: adhesive defect in thrombospondin 2-null fibroblasts is a consequence of increased levels of matrix metallo-proteinase-2. Mol. Biol. Cell 11, 3353-3364. (Pubitemid 30781937)
21. Schroen, B., Heymans, S., Sharma, U., Blankesteijn, W. M., Pokharel, S., Cleutjens, J. P., Porter, J. G., Evelo, C. T., Duisters, R., van Leeuwen, R. E., Janssen, B. J., Debets, J. J., Smits, J. F., Daemen, M. J., Crijns, H. J., Bornstein, P., Pinto, Y. M. (2004) Thrombospondin-2 is essential for myocardial matrix integrity: increased expression identifies failure-prone cardiac hypertrophy. Circ. Res. 95, 515-522. (Pubitemid 39180932)
22. Hahn-Dantona, E., Ruiz, J. F., Bornstein, P., Strickland, D. K. (2001) The low density lipoprotein receptor-related protein modulates levels of matrix metalloproteinase 9 (MMP-9) by mediating its cellular catabolism. J. Biol. Chem. 276, 15498-15503. (Pubitemid 37373445)
23. Visse, R., Nagase, H. (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 92, 827-839. (Pubitemid 36542523)
24. Ra, H. J., Parks, W. C. (2007) Control of matrix metalloproteinase catalytic activity. Matrix Biol. 26, 587-596.
25. Mott, J. D., Werb, Z. (2004) Regulation of matrix biology by matrix metalloproteinases. Curr. Opin. Cell Biol. 16, 558-564.
26. Parks, W. C., Wilson, C. L., Lopez-Boado, Y. S. (2004) Matrix metallo-proteinases as modulators of inflammation and innate immunity. Nat. Rev. Immunol. 4, 617-629. (Pubitemid 39025047)
27. Niyibizi, C., Chan, R., Wu, J. J., Eyre, D. (1994) A 92 kDa gelatinase (MMP-9) cleavage site in native type V collagen. Biochem. Biophys. Res. Commun. 202, 328-333. (Pubitemid 124009248)
28. Schonbeck, U., Mach, F., Libby, P. (1998) Generation of biologically active IL-1 β by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 β processing. J. Immunol. 161, 3340-3346. (Pubitemid 128470627)
29. Patterson, B. C., Sang, Q. A. (1997) Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9). J. Biol. Chem. 272, 28823-28825.
30. Van den Steen, P. E., Proost, P., Wuyts, A., Van Damme, J., Opdenakker, G. (2000) Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-α and leaves RANTES and MCP-2 intact. Blood 96, 2673-2681. (Pubitemid 30770359)
31. Yu, Q., Stamenkovic, I. (2000) Cell surface-localized matrix metalloproteinase- 9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis. Genes Dev. 14, 163-176. (Pubitemid 30070982)
32. McQuibban, G. A., Butler, G. S., Gong, J. H., Bendall, L., Power, C., Clark-Lewis, I., Overall, C. M. (2001) Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J. Biol. Chem. 276, 43503-43508. (Pubitemid 37383907)
33. Kyriakides, T. R., Hartzel, T., Huynh, G., Bornstein, P. (2001) Regulation of angiogenesis and matrix remodeling by localized, matrix-mediated antisense gene delivery. Mol. Ther. 3, 842-849. (Pubitemid 32611293)
34. Vu, T. H., Shipley, J. M., Bergers, G., Berger, J. E., Helms, J. A., Hanahan, D., Shapiro, S. D., Senior, R. M., Werb, Z. (1998) MMP-9/ gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93, 411-422. (Pubitemid 28232085)
35. Visscher, D. W., Hoyhtya, M., Ottosen, S. K., Liang, C. M., Sarkar, F. H., Crissman, J. D., Fridman, R. (1994) Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence. Int. J. Cancer 59, 339-344. (Pubitemid 24331823)
36. Kyriakides, T. R., Tam, J. W., Bornstein, P. (1999) Accelerated wound healing in mice with a disruption of the thrombospondin 2 gene. J. Invest. Dermatol. 113, 782-787.
37. Sundaram, K., Nishimura, R., Senn, J., Youssef, R. F., London, S. D., Reddy, S. V. (2007) RANK ligand signaling modulates the matrix metalloproteinase-9 gene expression during osteoclast differentiation. Exp. Cell Res. 313, 168-178. (Pubitemid 44958461)
38. Jones, J. A., McNally, A. K., Chang, D. T., Qin, L. A., Meyerson, H., Colton, E., Kwon, I. L., Matsuda, T., Anderson, J. M. (2008) Matrix metalloproteinases and their inhibitors in the foreign body reaction on biomaterials. J. Biomed. Mater. Res. A 84, 158-166. (Pubitemid 350244257)
39. Antczak, C., Radu, C., Djaballah, H. (2008) A profiling platform for the identification of selective metalloprotease inhibitors. J. Biomol. Screen. 13, 285-294.
40. Chabot, V., Reverdiau, P., Iochmann, S., Rico, A., Senecal, D., Goupille, C., Sizaret, P. Y., Sensebe, L. (2006) CCL5-enhanced human immature dendritic cell migration through the basement membrane in vitro depends on matrix metalloproteinase-9. J. Leukoc. Biol. 79, 767-778. (Pubitemid 44835608)
41. Rahat, M. A., Marom, B., Bitterman, H., Weiss-Cerem, L., Kinarty, A., Lahat, N. (2006) Hypoxia reduces the output of matrix metalloproteinase-9 (MMP-9) in monocytes by inhibiting its secretion and elevating membranal association. J. Leukoc. Biol. 79, 706-718. (Pubitemid 44835603)
42. McNally, A. K., Anderson, J. M. (2002) β1 and β2 integrins mediate adhesion during macrophage fusion and multinucleated foreign body giant cell formation. Am. J. Pathol. 160, 621-630.
43. Okuma, T., Terasaki, Y., Kaikita, K., Kobayashi, H., Kuziel, W. A., Kawasuji, M., Takeya, M. (2004) C-C chemokine receptor 2 (CCR2) deficiency improves bleomycin-induced pulmonary fibrosis by attenuation of both macrophage infiltration and production of macrophage-derived matrix metalloproteinases. J. Pathol. 204, 594-604. (Pubitemid 39585959)
44. Puissegur, M. P., Lay, G., Gilleron, M., Botella, L., Nigou, J., Marrakchi, H., Mari, B., Duteyrat, J. L., Guerardel, Y., Kremer, L., Barbry, P., Puzo, G., Altare, F. (2007) Mycobacterial lipomannan induces granuloma macrophage fusion via a TLR2-dependent, ADAM9- and β1 integrin-mediated pathway. J. Immunol. 178, 3161-3169. (Pubitemid 46333198)
45. Namba, K., Nishio, M., Mori, K., Miyamoto, N., Tsurudome, M., Ito, M., Kawano, M., Uchida, A., Ito, Y. (2001) Involvement of ADAM9 in multinucleated giant cell formation of blood monocytes. Cell. Immunol. 213, 104-113. (Pubitemid 34194831)
46. McNally, A. K., Jones, J. A., Macewan, S. R., Colton, E., Anderson, J. M. (2008) Vitronectin is a critical protein adhesion substrate for IL-4-induced foreign body giant cell formation. J. Biomed. Mater. Res. A 86, 535-543. (Pubitemid 351969652)
47. Tsai, A. T., Rice, J., Scatena, M., Liaw, L., Ratner, B. D., Giachelli, C. M. (2005) The role of osteopontin in foreign body giant cell formation. Biomaterials 26, 5835-5843. (Pubitemid 40803458)
48. Wucherpfennig, A. L., Li, Y. P., Stetler-Stevenson, W. G., Rosenberg, A. E., Stashenko, P. (1994) Expression of 92 kD type IV collagenase/ gelatinase B in human osteoclasts. J. Bone Miner. Res. 9, 549-556. (Pubitemid 24090338)
49. Kusano, K., Miyaura, C., Inada, M., Tamura, T., Ito, A., Nagase, H., Kamoi, K., Suda, T. (1998) Regulation of matrix metalloproteinases (MMP-2, -3, -9, and -13) by interleukin-1 and interleukin-6 in mouse calvaria: association of MMP induction with bone resorption. Endocrinology 139, 1338-1345. (Pubitemid 28510155)
50. Pajcini, K. V., Pomerantz, J. H., Alkan, O., Doyonnas, R., Blau, H. M. (2008) Myoblasts and macrophages share molecular components that contribute to cell- cell fusion. J. Cell Biol. 180, 1005-1019.
51. Witte, M. B., Thornton, F. J., Kiyama, T., Efron, D. T., Schulz, G. S., Moldawer, L. L., Barbul, A. (1998) Metalloproteinase inhibitors and wound healing: a novel enhancer of wound strength. Surgery 124, 464-470. (Pubitemid 28372950)
52. Belotti, D., Paganoni, P., Manenti, L., Garofalo, A., Marchini, S., Taraboletti, G., Giavazzi, R. (2003) Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation. Cancer Res. 63, 5224-5229. (Pubitemid 37139832)
53. Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., Hanahan, D. (2000) Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol. 2, 737-744. (Pubitemid 30768157)